LLMpediaThe first transparent, open encyclopedia generated by LLMs

morphine

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Pfizer Hop 4
Expansion Funnel Raw 75 → Dedup 41 → NER 8 → Enqueued 7
1. Extracted75
2. After dedup41 (None)
3. After NER8 (None)
Rejected: 33 (not NE: 33)
4. Enqueued7 (None)
Similarity rejected: 1
morphine
IUPAC name(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol
TradenameMS Contin, Oramorph, others
CAS number57-27-2
DrugBankDB00295
UNII76I7G6D29C

morphine. It is a potent opioid analgesic and the principal alkaloid found in the opium poppy, Papaver somniferum. First isolated in the early 19th century by Friedrich Sertürner, it has since become a cornerstone of pain management worldwide, particularly for severe acute and chronic pain such as that from myocardial infarction or cancer. Its profound effects on the central nervous system also make it a drug with high potential for substance dependence and public health crises.

History

The use of opium, the source material, dates back to ancient civilizations like Sumer and is well-documented in the works of Hippocrates and Galen. The critical breakthrough occurred in 1804 when the German pharmacist Friedrich Sertürner first isolated the active principle, naming it "morphium" after Morpheus, the Greek god of dreams. Its medical adoption accelerated following the invention of the hypodermic syringe by Alexander Wood in the 1850s, allowing direct administration. Widespread use during the American Civil War led to the first recognized wave of "soldier's disease," or addiction. The subsequent synthesis of derivatives like heroin by Felix Hoffmann at Bayer and the development of semi-synthetic opioids expanded its pharmacological legacy, while international control efforts began with treaties like the Single Convention on Narcotic Drugs.

Medical uses

It is primarily indicated for the relief of severe pain, such as that experienced during a myocardial infarction, post-surgical recovery, or in advanced stages of cancer. It is a World Health Organization Essential Medicine and is fundamental in palliative care protocols. Other uses include the treatment of acute pulmonary edema and as an adjunct to general anesthesia. It is administered via various routes, including oral formulations like MS Contin, intravenous injection, epidural infusion via an intrathecal pump, and patient-controlled analgesia devices. Its use is typically contraindicated in conditions like acute pancreatitis and severe bronchial asthma due to the risk of respiratory depression.

Adverse effects

Common side effects include nausea, vomiting, constipation, and sedation. More serious risks involve dose-dependent respiratory depression, which can be fatal, and the development of tolerance and physical dependence. Long-term use can lead to hormonal imbalance, such as hypogonadism, and immunosuppression. Overdose, often characterized by the classic triad of pinpoint pupils, unconsciousness, and respiratory failure, is a medical emergency treated with the competitive antagonist naloxone. The risk of overdose is significantly heightened when combined with other central nervous system depressants like alcohol or benzodiazepines.

Pharmacology

It exerts its effects primarily as an agonist at mu-opioid receptors (MOR) in the brainstem, thalamus, and spinal cord. Activation of these G protein-coupled receptors inhibits the release of neurotransmitters like substance P and hyperpolarizes neurons, reducing pain signal transmission. It is metabolized extensively in the liver by enzymes including UGT2B7 into active metabolites like morphine-6-glucuronide, which contribute to its analgesic effect. Its pharmacokinetics are variable, with oral bioavailability significantly lower than intravenous due to first-pass metabolism. The drug crosses the blood-brain barrier and the placenta, posing risks for neonatal abstinence syndrome.

Society and culture

Its dual identity as a vital medicine and a drug of abuse has deeply influenced global society. It is classified as a Schedule II controlled substance under the Controlled Substances Act in the United States and is similarly controlled worldwide by the International Narcotics Control Board. The widespread prescribing of opioid analgesics in the late 1990s, heavily promoted by pharmaceutical companies like Purdue Pharma, is cited as a major catalyst for the ongoing opioid epidemic in North America. It has a prominent place in literature and history, depicted in works by authors like Thomas De Quincey in Confessions of an English Opium-Eater and influencing the lives of figures such as Samuel Taylor Coleridge.

Chemistry

It is a phenanthrene alkaloid with a complex pentacyclic structure. Its chemical formula is C₁₇H₁₉NO₃, and it exists naturally as the levorotatory isomer. The molecule features a benzene ring fused to a partially saturated isoquinoline ring system and an ether bridge, creating the characteristic T-shape that fits the opioid receptor binding pocket. Key functional groups include two hydroxyl groups and a tertiary amine. It is the biosynthetic precursor to other opium alkaloids like codeine and thebaine. Semi-synthetic derivatives, created by modifying its structure, include hydromorphone, oxycodone, and the antagonist naltrexone.